BF Biosciences Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	598.64	447.15	385.41	149.05	306.98	607.99
Depreciation & Amortization	280.12	191.92	35.57	33.78	28	23
Other Amortization	1.98	1.69	0.55	0.55	-	-
Loss (Gain) From Sale of Assets	-4.36	-2.79	-2.13	-1.06	-	-
Loss (Gain) From Sale of Investments	-57.62	-27.3	-0.21	-8.93	-	-
Other Operating Activities	148.98	44.33	305.49	32.12	-156.98	-60.99
Change in Accounts Receivable	-357.29	20.37	-110.82	-41.1	-	-
Change in Inventory	-1,178	-846.4	-41.57	-445.69	-	-
Change in Accounts Payable	1,338	472.43	196.75	-5.94	-	-
Change in Unearned Revenue	90.67	-5.27	19.75	-17.78	-	-
Change in Other Net Operating Assets	-174.53	3.66	-124.09	108.94	-	-
Operating Cash Flow	714.17	299.79	664.7	-196.07	178	570
Operating Cash Flow Growth	27.64%	-54.90%	-	-	-68.77%	-
Capital Expenditures	-380.93	-329.49	-143.13	-1,968	-1,130	-941
Sale of Property, Plant & Equipment	6.52	3.86	4.4	1.06	-	-
Sale (Purchase) of Intangibles	-	-	-	-1.66	-	-
Investment in Securities	525.81	-1,100	108.58	1,161	-	-
Other Investing Activities	12.05	91	16.34	83.4	-333	-399
Investing Cash Flow	163.45	-1,335	-13.81	-724.44	-1,463	-1,340
Long-Term Debt Issued	-	93.55	-	811.02	-	-
Long-Term Debt Repaid	-	-436.19	-321.36	-50.5	-	-
Net Debt Issued (Repaid)	-441.52	-342.64	-321.36	760.52	-	-
Issuance of Common Stock	-	1,855	-	-	-	-
Other Financing Activities	-86.96	-112.25	-161.52	-120.28	925	1,162
Financing Cash Flow	-528.47	1,400	-482.88	640.24	925	1,162
Miscellaneous Cash Flow Adjustments	-	-	-	-	1	1
Net Cash Flow	349.15	365.04	168.02	-280.27	-359	393
Free Cash Flow	333.25	-29.71	521.57	-2,164	-952	-371
Free Cash Flow Margin	4.05%	-0.51%	14.26%	-119.61%	-62.60%	-21.14%
Free Cash Flow Per Share	3.77	-0.37	8.23	-34.17	-15.03	-5.86
Cash Interest Paid	86.96	112.25	161.52	120.28	-	-
Cash Income Tax Paid	257.34	279.05	51.39	73.4	-	-
Levered Free Cash Flow	226.73	-255.5	313.25	-2,306	-834	-670.45
Unlevered Free Cash Flow	274.92	-183.39	401.52	-2,306	-792.99	-654.66
Change in Working Capital	-280.84	-355.21	-59.98	-401.58	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.